Why AngioDynamics Stock Is Sinking Today
Shares of (NASDAQ: ANGO) were sinking 13.1% as of 11:02 a.m. ET. The sell-off came after the medical technology company announced its third-quarter results before the market open.
Those results were actually quite good. AngioDynamics reported Q3 revenue of $79.4 million, up 8.8% year-over-year on a pro forma basis and higher than the consensus Wall Street estimate of $76.4 million. The company posted an adjusted loss of $59,000, which amounted to roughly $0.00 per share. Analysts expected an adjusted net loss of $0.10 per share.
So why did this medical device stock sell off so heavily? Probably because AngioDynamics announced the unexpected retirement of CEO Jim Clemmer.
Source Fool.com
Angiodynamics Inc. Aktie
Unklare Tendenz: Angiodynamics Inc. mit nur wenigen Buy- und Sell-Einschätzungen.
Eine Steigerung von über 50% ist für Angiodynamics Inc. möglich, angesichts eines Kursziels von 13 € gegenüber 8.55 €.


